Éléments épinglés
Activités récentes
-
A.H., MD Muscular Dystrophy - Lebanon
Patient Information:
- Name: Alexey Nechaev
- Diagnosis: Progressive Muscular Dystrophy (Duchenne's)
- Date of Birth (D.O.B): January 3, 2002
- Gender: Male
- Country: Russia
Treatment: Nerve Growth Factor Therapy + Traditional Chinese Medicine (TCM) + Rehabilitation Therapy (Physical & Occupational Therapy)
Medical History:
Alexey, a 9-year-old boy from Russia, was admitted to Puhua International Hospital due to progressive weakness in all four limbs for seven years. He started falling while walking at age 2 and developed a "duck gait" at age 3. At age 5, he was diagnosed with Duchenne Muscular Dystrophy via genetic testing. He received medication and regular rehabilitation training.
Medical Condition Before Nerve Growth Factor Therapy:
- Alert, normal emotion, cognition, and speech
- Poor muscle power in trunk and limbs; felt helpless with daily movements
- Muscular atrophy in all four limbs
- Balance and flexibility of movement impaired
- Walked alone for approximately 20 steps with difficulty; abdomen and pelvis had excessive anterior tilt; soles of feet did not touch the ground properly
- Had difficulty getting up from a chair or bed after prolonged sitting
Nerve Growth Factor Therapy for Muscular Dystrophy:
- Injections of neural nerve growth factors
- Traditional Chinese Medicine (TCM)
- Rehabilitation therapy (physical & occupational therapy)
Medical Condition After Nerve Growth Factor Therapy:
- Improvement noted from first injection:
- Quickened transition from sitting to standing
- Improved muscle strength and volume; gained approximately 3 kg in weight
- Reduced excessive anterior tilt of abdomen and pelvis while walking
- Easier standing up and stepping forward compared to prior condition
- Left foot sole completely touched ground; right foot sole mostly touched ground during gait
- Now able to:
- Go to the toilet independently
- Walk approximately 50 meters
- Throw ball horizontally for 2 meters in rehabilitation training
- Complete more than 20 minutes of rehabilitation training without obvious fatigue
Publication en cours de modération
Statut publié avec succès. Il est désormais visible dans votre journal.
-
A.H., MD Muscular Dystrophy - Lebanon
Patient Information:
- Name: Alexey Nechaev
- Diagnosis: Progressive Muscular Dystrophy (Duchenne's)
- Date of Birth (D.O.B): January 3, 2002
- Gender: Male
- Country: Russia
Treatment: Nerve Growth Factor Therapy + Traditional Chinese Medicine (TCM) + Rehabilitation Therapy (Physical & Occupational Therapy)
Medical History:
Alexey, a 9-year-old boy from Russia, was admitted to Puhua International Hospital due to progressive weakness in all four limbs for seven years. He started falling while walking at age 2 and developed a "duck gait" at age 3. At age 5, he was diagnosed with Duchenne Muscular Dystrophy via genetic testing. He received medication and regular rehabilitation training.
Medical Condition Before Nerve Growth Factor Therapy:
- Alert, normal emotion, cognition, and speech
- Poor muscle power in trunk and limbs; felt helpless with daily movements
- Muscular atrophy in all four limbs
- Balance and flexibility of movement impaired
- Walked alone for approximately 20 steps with difficulty; abdomen and pelvis had excessive anterior tilt; soles of feet did not touch the ground properly
- Had difficulty getting up from a chair or bed after prolonged sitting
Nerve Growth Factor Therapy for Muscular Dystrophy:
- Injections of neural nerve growth factors
- Traditional Chinese Medicine (TCM)
- Rehabilitation therapy (physical & occupational therapy)
Medical Condition After Nerve Growth Factor Therapy:
- Improvement noted from first injection:
- Quickened transition from sitting to standing
- Improved muscle strength and volume; gained approximately 3 kg in weight
- Reduced excessive anterior tilt of abdomen and pelvis while walking
- Easier standing up and stepping forward compared to prior condition
- Left foot sole completely touched ground; right foot sole mostly touched ground during gait
- Now able to:
- Go to the toilet independently
- Walk approximately 50 meters
- Throw ball horizontally for 2 meters in rehabilitation training
- Complete more than 20 minutes of rehabilitation training without obvious fatigue
Publication en cours de modération
Statut publié avec succès. Il est désormais visible dans votre journal.
-
Parkinson’s Disease: Advances in Treatment Therapy
Overview
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine-producing neurons in the brain. This condition leads to a variety of motor and non-motor symptoms that can significantly impact the quality of life for those affected. Approximately 10 million people worldwide are living with Parkinson’s Disease, making it a significant public health concern[1]. Understanding the underlying mechanisms, symptoms, and treatment options is essential for effectively managing this condition[2,3].
Symptoms
The symptoms of Parkinson's Disease can be broadly categorized into motor and non-motor symptoms:
Motor Symptoms:
- Tremors: Often starting in one hand or foot, tremors are a common symptom of PD[4].
- Bradykinesia: A slowing of movement that can affect the ability to perform daily tasks[5].
- Rigidity: Increased stiffness in the arms and legs[6].
- Postural Instability: Difficulty with balance and walking[7].
Non-Motor Symptoms:
- Sleep Disturbances: Issues such as insomnia or excessive daytime sleepiness[8].
- Cognitive Impairment: Difficulties with memory, attention, and problem-solving[9].
- Mood Disorders: Conditions such as depression, anxiety, or mood swings[10].
- Autonomic Dysfunction: Abnormalities in blood pressure, heart rate, and sweating[11].
Current Treatment Options
While there is no cure for Parkinson's Disease, various treatment options can help manage symptoms and improve quality of life, including:
Medications
A variety of medications are available to treat motor symptoms, such as:
- Levodopa/Carbidopa: A combination medication that converts levodopa into dopamine in the brain[12].
- Dopamine Agonists: Medications that stimulate dopamine receptors in the brain[13].
- MAO-B Inhibitors: Medications that prevent the breakdown of dopamine in the brain[14].
- Anticholinergic Medications: Medications that reduce muscle stiffness and tremors[15].
Surgical Treatments
- Magnetic Resonance-Guided Focused Ultrasound (MRgFUS): A non-invasive procedure used to treat motor symptoms[17].
- Robot-assisted stereotactic brain surgery: inject neural growth factor and repair injured nerves.
Rehabilitation and Supportive Care
- Physical Therapy: Helps improve movement and strength[18].
- Occupational Therapy: Assists in managing daily activities[19].
- Speech Therapy: Addresses communication and swallowing difficulties[20].
- Traditional Chinese Medicine (TCM): Various modalities can help manage non-motor symptoms and improve overall quality of life[21].
Treatment Options at Beijing Puhua International Hospital
Our hospital offers a range of treatment options for Parkinson's Disease, including:
-
Medications: We use the latest medications to manage motor symptoms, including levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and anticholinergic medications.
-
Surgical Treatments: Our expert neurosurgeons perform deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) procedures to provide relief from motor symptoms.
-
Rehabilitation and Supportive Care: We offer physical therapy, occupational therapy, speech therapy, and traditional Chinese medicine (TCM) modalities to help manage non-motor symptoms and improve overall quality of life.
References
-
Parkinson’s Foundation. (2022). Parkinson’s Disease Statistics.
-
Dorsey, E. R., et al. (2018). “The Global Burden of Parkinson’s Disease: A Systematic Review.” Movement Disorders.
-
Kalia, L. V., & Lang, A. E. (2015). “Parkinson’s Disease.” Lancet.
-
Jankovic, J. (2008). “Parkinson's Disease: Clinical Features and Diagnosis.” Journal of Neurology, Neurosurgery & Psychiatry.
-
Postuma, R. B., et al. (2015). “Identifying Prodromal Parkinson's Disease: A Systematic Review.” Movement Disorders.
-
Fahn, S., & Cohen, J. (1992). “The Neurology of Parkinson's Disease.” Clinical Neurology and Neurosurgery.
-
Sutherland, H. S., et al. (2019). “Postural Stability and Mobility in Patients with Parkinson’s Disease.” Clinical Neurophysiology.
-
Chahine, L. M., et al. (2020). “Sleep Disorders in Parkinson’s Disease.” Parkinsonism & Related Disorders.
-
Aarsland, D., et al. (2011). “Cognitive Impairment in Parkinson's Disease: Clinical, Pathophysiological, and Treatment Aspects.” Nature Reviews Neurology.
-
O'Sullivan, S. S., et al. (2009). “Non-motor Symptoms in Parkinson’s Disease.” Journal of Neurology, Neurosurgery & Psychiatry.
-
Schapira, A. H. V. (2008). “Mitochondria in the etiology and pathogenesis of Parkinson’s disease.” Movement Disorders.
-
Marsden, C. D. (1989). “The History of Parkinson's Disease.” Journal of Neurology.
-
Bhatia, K. P., & Marsden, C. D. (1994). “The Behavioral Neurology of Movement Disorders.” Movement Disorders.
-
LeWitt, P. A. (2015). “Levodopa for the Treatment of Parkinson’s Disease.” New England Journal of Medicine.
-
Olanow, C. W., et al. (2009). “Molecular Pathways for the Treatment of Parkinson’s Disease.” Movement Disorders.
-
Benabid, A. L., et al. (2009). “Deep Brain Stimulation for Parkinson's Disease.” Lancet Neurology.
-
Rachmany, L., et al. (2020). “MRI-guided Focused Ultrasound for Parkinson’s Disease: A Review.” Journal of Neuroimaging.
-
Awan, N. R., et al. (2016). “Role of Physiotherapy in Parkinson’s Disease: A Review.” Clinical Rehabilitation.
-
Matar, N., et al. (2016). “Occupational Therapy for Patients with Parkinson's Disease.” Journal of Rehabilitation Medicine.
-
O'Reilly, C., et al. (2019). “Speech Therapy in Parkinson’s Disease.” Journal of Neurology.
-
Lu, H., et al. (2013). “Traditional Chinese Medicine for Parkinson’s Disease: A Review.” Journal of Traditional Chinese Medicine.
-
Barker, R. A., et al. (2013). “Regenerative Medicine and Parkinson’s Disease.” Nature Reviews Neurology.
Publication en cours de modération
Statut publié avec succès. Il est désormais visible dans votre journal.
-
Parkinson’s Disease: Advances in Treatment Therapy
Overview
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine-producing neurons in the brain. This condition leads to a variety of motor and non-motor symptoms that can significantly impact the quality of life for those affected. Approximately 10 million people worldwide are living with Parkinson’s Disease, making it a significant public health concern[1]. Understanding the underlying mechanisms, symptoms, and treatment options is essential for effectively managing this condition[2,3].
Symptoms
The symptoms of Parkinson's Disease can be broadly categorized into motor and non-motor symptoms:
Motor Symptoms:
- Tremors: Often starting in one hand or foot, tremors are a common symptom of PD[4].
- Bradykinesia: A slowing of movement that can affect the ability to perform daily tasks[5].
- Rigidity: Increased stiffness in the arms and legs[6].
- Postural Instability: Difficulty with balance and walking[7].
Non-Motor Symptoms:
- Sleep Disturbances: Issues such as insomnia or excessive daytime sleepiness[8].
- Cognitive Impairment: Difficulties with memory, attention, and problem-solving[9].
- Mood Disorders: Conditions such as depression, anxiety, or mood swings[10].
- Autonomic Dysfunction: Abnormalities in blood pressure, heart rate, and sweating[11].
Current Treatment Options
While there is no cure for Parkinson's Disease, various treatment options can help manage symptoms and improve quality of life, including:
Medications
A variety of medications are available to treat motor symptoms, such as:
- Levodopa/Carbidopa: A combination medication that converts levodopa into dopamine in the brain[12].
- Dopamine Agonists: Medications that stimulate dopamine receptors in the brain[13].
- MAO-B Inhibitors: Medications that prevent the breakdown of dopamine in the brain[14].
- Anticholinergic Medications: Medications that reduce muscle stiffness and tremors[15].
Surgical Treatments
- Magnetic Resonance-Guided Focused Ultrasound (MRgFUS): A non-invasive procedure used to treat motor symptoms[17].
- Robot-assisted stereotactic brain surgery: inject neural growth factor and repair injured nerves.
Rehabilitation and Supportive Care
- Physical Therapy: Helps improve movement and strength[18].
- Occupational Therapy: Assists in managing daily activities[19].
- Speech Therapy: Addresses communication and swallowing difficulties[20].
- Traditional Chinese Medicine (TCM): Various modalities can help manage non-motor symptoms and improve overall quality of life[21].
Treatment Options at Beijing Puhua International Hospital
Our hospital offers a range of treatment options for Parkinson's Disease, including:
-
Medications: We use the latest medications to manage motor symptoms, including levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and anticholinergic medications.
-
Surgical Treatments: Our expert neurosurgeons perform deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) procedures to provide relief from motor symptoms.
-
Rehabilitation and Supportive Care: We offer physical therapy, occupational therapy, speech therapy, and traditional Chinese medicine (TCM) modalities to help manage non-motor symptoms and improve overall quality of life.
References
-
Parkinson’s Foundation. (2022). Parkinson’s Disease Statistics.
-
Dorsey, E. R., et al. (2018). “The Global Burden of Parkinson’s Disease: A Systematic Review.” Movement Disorders.
-
Kalia, L. V., & Lang, A. E. (2015). “Parkinson’s Disease.” Lancet.
-
Jankovic, J. (2008). “Parkinson's Disease: Clinical Features and Diagnosis.” Journal of Neurology, Neurosurgery & Psychiatry.
-
Postuma, R. B., et al. (2015). “Identifying Prodromal Parkinson's Disease: A Systematic Review.” Movement Disorders.
-
Fahn, S., & Cohen, J. (1992). “The Neurology of Parkinson's Disease.” Clinical Neurology and Neurosurgery.
-
Sutherland, H. S., et al. (2019). “Postural Stability and Mobility in Patients with Parkinson’s Disease.” Clinical Neurophysiology.
-
Chahine, L. M., et al. (2020). “Sleep Disorders in Parkinson’s Disease.” Parkinsonism & Related Disorders.
-
Aarsland, D., et al. (2011). “Cognitive Impairment in Parkinson's Disease: Clinical, Pathophysiological, and Treatment Aspects.” Nature Reviews Neurology.
-
O'Sullivan, S. S., et al. (2009). “Non-motor Symptoms in Parkinson’s Disease.” Journal of Neurology, Neurosurgery & Psychiatry.
-
Schapira, A. H. V. (2008). “Mitochondria in the etiology and pathogenesis of Parkinson’s disease.” Movement Disorders.
-
Marsden, C. D. (1989). “The History of Parkinson's Disease.” Journal of Neurology.
-
Bhatia, K. P., & Marsden, C. D. (1994). “The Behavioral Neurology of Movement Disorders.” Movement Disorders.
-
LeWitt, P. A. (2015). “Levodopa for the Treatment of Parkinson’s Disease.” New England Journal of Medicine.
-
Olanow, C. W., et al. (2009). “Molecular Pathways for the Treatment of Parkinson’s Disease.” Movement Disorders.
-
Benabid, A. L., et al. (2009). “Deep Brain Stimulation for Parkinson's Disease.” Lancet Neurology.
-
Rachmany, L., et al. (2020). “MRI-guided Focused Ultrasound for Parkinson’s Disease: A Review.” Journal of Neuroimaging.
-
Awan, N. R., et al. (2016). “Role of Physiotherapy in Parkinson’s Disease: A Review.” Clinical Rehabilitation.
-
Matar, N., et al. (2016). “Occupational Therapy for Patients with Parkinson's Disease.” Journal of Rehabilitation Medicine.
-
O'Reilly, C., et al. (2019). “Speech Therapy in Parkinson’s Disease.” Journal of Neurology.
-
Lu, H., et al. (2013). “Traditional Chinese Medicine for Parkinson’s Disease: A Review.” Journal of Traditional Chinese Medicine.
-
Barker, R. A., et al. (2013). “Regenerative Medicine and Parkinson’s Disease.” Nature Reviews Neurology.
Publication en cours de modération
Statut publié avec succès. Il est désormais visible dans votre journal.
-
Parkinson’s Disease: Advances in Treatment Therapy
Overview
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine-producing neurons in the brain. This condition leads to a variety of motor and non-motor symptoms that can significantly impact the quality of life for those affected. Approximately 10 million people worldwide are living with Parkinson’s Disease, making it a significant public health concern[1]. Understanding the underlying mechanisms, symptoms, and treatment options is essential for effectively managing this condition[2,3].
Symptoms
The symptoms of Parkinson's Disease can be broadly categorized into motor and non-motor symptoms:
Motor Symptoms:
- Tremors: Often starting in one hand or foot, tremors are a common symptom of PD[4].
- Bradykinesia: A slowing of movement that can affect the ability to perform daily tasks[5].
- Rigidity: Increased stiffness in the arms and legs[6].
- Postural Instability: Difficulty with balance and walking[7].
Non-Motor Symptoms:
- Sleep Disturbances: Issues such as insomnia or excessive daytime sleepiness[8].
- Cognitive Impairment: Difficulties with memory, attention, and problem-solving[9].
- Mood Disorders: Conditions such as depression, anxiety, or mood swings[10].
- Autonomic Dysfunction: Abnormalities in blood pressure, heart rate, and sweating[11].
Current Treatment Options
While there is no cure for Parkinson's Disease, various treatment options can help manage symptoms and improve quality of life, including:
Medications
A variety of medications are available to treat motor symptoms, such as:
- Levodopa/Carbidopa: A combination medication that converts levodopa into dopamine in the brain[12].
- Dopamine Agonists: Medications that stimulate dopamine receptors in the brain[13].
- MAO-B Inhibitors: Medications that prevent the breakdown of dopamine in the brain[14].
- Anticholinergic Medications: Medications that reduce muscle stiffness and tremors[15].
Surgical Treatments
- Magnetic Resonance-Guided Focused Ultrasound (MRgFUS): A non-invasive procedure used to treat motor symptoms[17].
- Robot-assisted stereotactic brain surgery: inject neural growth factor and repair injured nerves.
Rehabilitation and Supportive Care
- Physical Therapy: Helps improve movement and strength[18].
- Occupational Therapy: Assists in managing daily activities[19].
- Speech Therapy: Addresses communication and swallowing difficulties[20].
- Traditional Chinese Medicine (TCM): Various modalities can help manage non-motor symptoms and improve overall quality of life[21].
Treatment Options at Beijing Puhua International Hospital
Our hospital offers a range of treatment options for Parkinson's Disease, including:
-
Medications: We use the latest medications to manage motor symptoms, including levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and anticholinergic medications.
-
Surgical Treatments: Our expert neurosurgeons perform deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) procedures to provide relief from motor symptoms.
-
Rehabilitation and Supportive Care: We offer physical therapy, occupational therapy, speech therapy, and traditional Chinese medicine (TCM) modalities to help manage non-motor symptoms and improve overall quality of life.
References
-
Parkinson’s Foundation. (2022). Parkinson’s Disease Statistics.
-
Dorsey, E. R., et al. (2018). “The Global Burden of Parkinson’s Disease: A Systematic Review.” Movement Disorders.
-
Kalia, L. V., & Lang, A. E. (2015). “Parkinson’s Disease.” Lancet.
-
Jankovic, J. (2008). “Parkinson's Disease: Clinical Features and Diagnosis.” Journal of Neurology, Neurosurgery & Psychiatry.
-
Postuma, R. B., et al. (2015). “Identifying Prodromal Parkinson's Disease: A Systematic Review.” Movement Disorders.
-
Fahn, S., & Cohen, J. (1992). “The Neurology of Parkinson's Disease.” Clinical Neurology and Neurosurgery.
-
Sutherland, H. S., et al. (2019). “Postural Stability and Mobility in Patients with Parkinson’s Disease.” Clinical Neurophysiology.
-
Chahine, L. M., et al. (2020). “Sleep Disorders in Parkinson’s Disease.” Parkinsonism & Related Disorders.
-
Aarsland, D., et al. (2011). “Cognitive Impairment in Parkinson's Disease: Clinical, Pathophysiological, and Treatment Aspects.” Nature Reviews Neurology.
-
O'Sullivan, S. S., et al. (2009). “Non-motor Symptoms in Parkinson’s Disease.” Journal of Neurology, Neurosurgery & Psychiatry.
-
Schapira, A. H. V. (2008). “Mitochondria in the etiology and pathogenesis of Parkinson’s disease.” Movement Disorders.
-
Marsden, C. D. (1989). “The History of Parkinson's Disease.” Journal of Neurology.
-
Bhatia, K. P., & Marsden, C. D. (1994). “The Behavioral Neurology of Movement Disorders.” Movement Disorders.
-
LeWitt, P. A. (2015). “Levodopa for the Treatment of Parkinson’s Disease.” New England Journal of Medicine.
-
Olanow, C. W., et al. (2009). “Molecular Pathways for the Treatment of Parkinson’s Disease.” Movement Disorders.
-
Benabid, A. L., et al. (2009). “Deep Brain Stimulation for Parkinson's Disease.” Lancet Neurology.
-
Rachmany, L., et al. (2020). “MRI-guided Focused Ultrasound for Parkinson’s Disease: A Review.” Journal of Neuroimaging.
-
Awan, N. R., et al. (2016). “Role of Physiotherapy in Parkinson’s Disease: A Review.” Clinical Rehabilitation.
-
Matar, N., et al. (2016). “Occupational Therapy for Patients with Parkinson's Disease.” Journal of Rehabilitation Medicine.
-
O'Reilly, C., et al. (2019). “Speech Therapy in Parkinson’s Disease.” Journal of Neurology.
-
Lu, H., et al. (2013). “Traditional Chinese Medicine for Parkinson’s Disease: A Review.” Journal of Traditional Chinese Medicine.
-
Barker, R. A., et al. (2013). “Regenerative Medicine and Parkinson’s Disease.” Nature Reviews Neurology.
Publication en cours de modération
Statut publié avec succès. Il est désormais visible dans votre journal.
Vous devez avoir un compte pour consulter le reste des éléments du journal.
Impossible de charger le contenu de l'info-bulle.